Subretinal fluid may protect against macular atrophy in neovascular age‐related macular degeneration: 5 years of follow‐up from Fight Retinal Blindness registry-Reference-Cited by-同舟云学术

Subretinal fluid may protect against macular atrophy in neovascular age‐related macular degeneration: 5 years of follow‐up from Fight Retinal Blindness registry

Published:2022-12-19 Issue: Volume: Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Sánchez‐Monroy Jorge¹^ORCID,Nguyen Vuong²,Puzo Martin¹,Calvo Pilar¹,Arruabarrena Carolina³^ORCID,Monaco Pietro⁴,Chilov Michael⁵,Keegan David⁶,Barthelmes Daniel²⁷,Gillies Mark²

Affiliation:

1. Department of Ophthalmology Miguel Servet University Hospital Zaragoza Spain

2. Discipline of Ophthalmology Save Sight Institute, the University of Sydney, Sydney Medical School Sydney Australia

3. Department of Ophthalmology University Hospital of Alcalá de Henares Madrid Spain

4. Department of Ophthalmology San Martino Hospital Belluno Italy

5. Department of Ophthalmology Concord Repatriation Hospital Sydney New South Wales Australia

6. Mater Private Hospital Dublin Ireland

7. Department of Ophthalmology Zurich, University Hospital Zurich University of Zurich Zurich Switzerland

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.15309

Reference28 articles.

1. The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study

3. Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration

4. Impact of fluid compartments on functional outcomes for patients with neovascular age‐related macular degeneration: A systematic literature review;Chaudhary V.;Retina,2022

5. Progression of macular atrophy in patients undergoing anti‐vascular endothelial growth factor therapy for neovascular age‐related macular degeneration

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AI-driven discovery of blood xenobiotic biomarkers in neovascular age-related macular degeneration using iterative random forests;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-06-06

2. Analysis of prognostic and predictive factors in neovascular age‐related macular degeneration Kuopio cohort;Acta Ophthalmologica;2024-04-10